Pacific Biosciences
PACB
PACB
106 hedge funds and large institutions have $406M invested in Pacific Biosciences in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less funds holding
Funds holding: 115 → 106 (-9)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
94% less call options, than puts
Call options by funds: $244K | Put options by funds: $4.09M
Holders
106
Holding in Top 10
3
Calls
$244K
Puts
$4.09M
Top Buyers
| 1 | +$77.8M | |
| 2 | +$40.6M | |
| 3 | +$25.5M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$12.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.61M |
Top Sellers
| 1 | -$29.5M | |
| 2 | -$9.34M | |
| 3 | -$4.83M | |
| 4 |
LCS
Levin Capital Strategies
New York
|
-$3.97M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.88M |